Dow Up 0.00% Nasdaq Up 0.09%

Alimera Sciences, Inc. (ALIM)

-NasdaqGM
5.87 Down 0.16(2.65%) Nov 28, 1:00PM EST
Prev Close:6.03
Open:5.97
Bid:5.80 x 100
Ask:5.96 x 100
1y Target Est:11.00
Beta:3.63
Earnings Date:Feb 25 - Mar 2 (Est.)
Day's Range:5.56 - 6.18
52wk Range:2.14 - 8.44
Volume:172,965
Avg Vol (3m):390,736
Market Cap:260.02M
P/E (ttm):N/A
EPS (ttm):-1.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALIM

Comparison

Symbol% ChgMkt Cap
ALIMDown 2.65%260.02M
AGNDown 0.05%63.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Dec-14) :-0.16
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback